Font Size: a A A
Keyword [Idarubicin]
Result: 1 - 20 | Page: 1 of 2
1. In Vitro Study Of Effects And Mechanisms Of MTOR Inhibitor Rapamycin On Human T-cell Acute Lymphoblastic Leukemia Cells
2. Investigation On The Role Of Acute Leukemic Bone Marrow Stroma In Residual Leukemia Development
3. Result Of Comparing Cytarbine And Daunorubicin With Cytarbine And Idarubicin Or Cytarbine And Homoharringtonince In Pations With Acute Myeloid Leukemia
4. The Analysis Of Anti-leukemia Curative Effect Of Idarubicin
5. Idarubicin Based Regimen For Patients With Hematologic Malignancies Involving Central Nervous System
6. Induction Of Apoptosis In Leukemia Cell Line K562 By Bortezomib In Combination With Idarubicin
7. Analysis Of The Efficacy And The Toxic Side Effect Of Idarubicin When Used With Cytosine Arabinoside As Induction Chemotherapy For Newly Diagnosed Acute Myeloid Leukemia
8. Clinical Research On Idarubicin Intensified BuCy2 Conditioning Regimen In Patients Undergoing Allogeneic Stem Cell Transplantation For High-risk Hematological Malignancies
9. Mechanism Exploring Of EGCG In Enhancing Idarubicin Antitumor Activity And Functional Research Of Glol In HCC Development
10. Detection Of MDR1 And BAALC Gene Expression In De Novo Acute Myeloid Leukemia Patients And The Role Of MDR1 For Induction Chemotherapy
11. Synergistic Depression Of Wnt/β-catenin Pathway By Sequential Combination Of Decitabine And Idarubicin In Human Myeloid Leukemic Cell Lines
12. Clinical Response Of IA Compared With DA Regimens In The Treatment Of Newly Diagnosed Acute Myeloid Leukemia
13. Analysis Of High-dose Cytarabine Consolidation Therapy For Acute Myeloid Leukemia
14. Comparison Of DA And IA Protocol In Treatment Of Newly Diagnosed Acute Myeloid Leukemia In Adults
15. Combination Therapy Based On Daunorubicin Or Idarubicin For Patients With Newly Diagnosed Acute Myeloid Leukemia
16. The Study On IA And DA Regimens For Remission Induction Treatment Of Aged Acute Myeloid Leukemia
17. Clinical Analysis Of Hematopoietic Stem Cell Transplantation For Treatment Of42Patients With Acute Myeloid Leukemia
18. The Differences In The Curative Effect And Prognosis For Acute Myeloid Leukemia M2a Patients Cured By IA And DA Methods
19. A Retrospective Study Of Different Dose Idarubicin-based Induction Regimens For Young Patients With De-novo Acute Myeloid Leukemia
20. Clinical Study Of IA Protocol On The Efficacy And Side Effects In Patients With Acute Myeloid Leukemia
  <<First  <Prev  Next>  Last>>  Jump to